Elura® is a first-in-class ghrelin receptor agonist that safely addresses weight loss in cats with CKD for the long term.
Capromorelin is classified as an appetite stimulant and is used to increase the appetite of cats experiencing poor appetite or weight loss. Elura specifically is FDA approved for use in cats with chronic kidney disease (CKD) to help them gain weight.
Elura is the only FDA-approved treatment specifically designed for the management of weight loss in cats with chronic kidney disease (CKD). Elura should be administered directly into your cat's mouth. If the cat is routinely fed meals, offer food 30 minutes after dosing.
Mirataz (mirtazapine) and Elura (capromorelin) are approved to manage undesired weight loss in cats. Elura is specifically for cats with kidney disease.
Elura is a prescription medication used for the management of weight loss in cats with chronic kidney disease. Elura contains capromorelin, an appetite stimulant, that works by stimulating certain areas of the brain responsible for a cat’s appetite and hunger.
Elura for Cats - Management of Weight Loss - CKD | VetRxDirect
ELURA (capromorelin oral solution) is the first FDA approved product for management of weight loss in cats with chronic kidney disease. Capromorelin is a ghrelin receptor agonist known to increase appetite and weight gain and is approved as ENTYCE® for appetite stimulation in dogs.
Elura® (capromorelin oral solution) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for use in cats. It is indicated for the management of weight loss in cats with chronic kidney disease.
Capromorelin is classified as an appetite stimulant and is used to increase the appetite of cats experiencing poor appetite or weight loss. Elura specifically is FDA approved for use in cats with …